neurodAIgnostics team secures Innosuisse Project grant

With the support of Innosuisse, we will combine advanced sensing technologies and artificial intelligence to develop smart scoring solutions that enhance cognitive test precision while reducing neuropsychologists’ workload.

This project is made possible through close collaboration with expert teams led by Sandra Loosli at Universitätsspital Zürich (USZ) and Christopher Moufawad el Achkar at CSEM. Over the next 18 months, our joint efforts will focus on developing a robust prototype, conducting clinical pilot studies, and refining our platform based on real-world feedback from clinical environments.

We extend heartfelt thanks to the Innosuisse committee for their support. Thank you also to all the teams and individuals who generously provided guidance throughout the process, including those at the Translational Medicine Accelerator (TMA) and the USZ Health Innovation Hub. This R&D milestone lays a strong foundation for long-term, sustainable innovation that supports clinicians and improves patient care.

Are you a neuropsychologist or a clinical trial organisation interested in learning more? We would love to hear from you. Please contact us to explore how we can collaborate.